GVGabriel de Deus Vieira

Gabriel de Deus Vieira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabriel de Deus Vieira has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Procerus sign as a diagnostic clue for progressive supranuclear palsy

    by Gabriel de Deus Vieira, Ed Cleso Pereira de Souza Filho, Gabriel Erzinger, Miline Weis Becker, Marcelo Henrique de Moura Campos, Eduardo Rosa, Laura Fiuza Parolin, Marcus Vinícius Magno Gonçalves, Ylmar Corrêa Neto

    The procerus sign is associated with some diseases that initially manifest as atypical parkinsonism, especially progressive supranuclear palsy (PSP). It is described as a vertical contraction of the muscles in the glabellar region. This sign helps to clinically differentiate atypical parkinsonism diseases, especially in the early stages, when many conditions are similar, in terms of clinical presentation and poor response to levodopa. Thus, the procerus sign can be an important clue in the suspicion of PSP.

  • Cranial neuropathies related to immune checkpoint inhibitors

    by Gabriel de Deus Vieira, Vinícius de Oliveira Boldrini, Luana Schlindwen, Ed Cleso Pereira de Souza Filho, Maria Eduarda Schulz, Felipe Fanine de Souza, Julia Petry Trevisani, Pedro Higor Campezato, Amanda Haag, Marcus Vinicius Magno Gonçalves


  • Open Access

    Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database

    by Alfredo Damasceno, Cintia Ramari, Carlos Tauil, Henry Koiti Sato, Dagoberto Callegaro, Maria Fernanda Mendes, José Artur Costa D'ALmeida, Denise Sisterolli Diniz, Osvaldo J. M. Nascimento, Laura Parolin, et al.

    Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder whose prevalence varies across Brazil (from 15–27 cases per 100 thousand inhabitants), and the absence of an extensive national study limits the understanding of MS epidemiology in a nation as diverse as Brazil. To compare epidemiological data, including healthcare access, among people with MS across four Brazilian regions. Data from 2,974 Brazilian MS patients in the Collaborative Latin American Database for Multiple Sclerosis (BRANDO) were analyzed. We assessed demographic and clinical outcomes, as well as healthcare access, to elucidate regional differences. The cohort was predominantly composed of female patients (72.5%) with MS onset at a mean age of 30.6 years. Regarding the regional differences, there was a lower predominance of female patients (68.7%; p = 0.003) in the Southeast, a higher rate of subjects of mixed ethnicity (p < 0.001) in the Midwest (40.3%) and Northeast (63.7%), higher scores on the Expanded Disability Status Scale (EDSS) in the Northeast (4.0; p < 0.001), a higher prevalence of relapsing-remitting MS (RRMS) in the Southeast and Midwest (87%; p < 0.001), while the Northeast presented (p < 0.001) the highest rates of primary progressive MS (PPMS) and secondary progressive MS (SPMS) (PPMS = 15.8%; SPMS = 18%). The Northeast presented the longest time (5.9 years; p < 0.01) from disease onset until MS diagnosis (range for the other regions = 1.9–3.7 years). And the Midwest showed the shortest time (2.1 years; p < 0.01) from disease onset until first access to disease-modifying therapies (DMTs; range for the other regions = 3.5–5.1 years). The present is the first nationwide epidemiological study on people with MS in Brazil. It underscores regional epidemiological variations and differences in healthcare access, advocating for tailored approaches in MS management and research.


  • Open Access

    Anti-pan-neurofascin IgG3: insights about an emerging autoimmune nodoparanodopathy

    by Gabriel Erzinger, Mayra Emi Guinoza Inushi, Laura Fiuza Parolin, Gabriel de Deus Vieira, Marcus Vinícius Magno Gonçalves

    Neurofascin constitutes a family of cell-surface proteins identified more than 4 decades ago, produced through alternative RNA splicing, with various isoforms expressed in neural tissues. With the emergence of chronic inflammatory demyelinating polyneuropathy (CIDP) subtypes characterized by distinct pathological mechanisms, antineurofascin antibody-mediated neuropathies have gained attention and are now categorized as autoimmune nodoparanodopathies. Among these, the anti-pan-neurofascin immunoglobulin G3 (IgG3) subtype presents a particularly severe and diagnostically-challenging phenotype, marked by a fulminant clinical course, diverse symptomatology, and high rates of morbidity and mortality. Despite its clinical relevance, to date, no comprehensive review has focused specifically on this manifestation, highlighting a significant gap in the literature. To address this, we herein review the seven reported cases and explore the proposed pathophysiological mechanism involving the destruction of the node of Ranvier via hyperactivation of membrane attack complex (MAC) formation. Additionally, we examine emerging evidence supporting the use of eculizumab as a potential therapeutic option, alongside other treatment strategies. Finally, we discuss the role of standardized antibody assays, serological analyses, and neurophysiological studies in improving diagnostic accuracy.

  • Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders

    by Gabriel de Deus Vieira, Vinícius Oliveira Boldrini, Simone Mader, Tania Kümpfel, Edgar Meinl, Alfredo Damasceno


  • Open Access

    Spectrum of Neuroimmunological Manifestations of Dengue Fever

    by Gabriel de Deus Vieira, Marcelo Henrique De Moura Campos, Felipe Fanine de Souza, Isabelle Pastor Bandeira, Leticia Caroline Breis, Laura Fiuza Parolin, Júlia Machado Rickli, Caio César Demore, Beatriz Sordi Chara, Marco Antônio Machado Schlindwein, et al.


  • Open Access

    Diffusion-tensor imaging findings related to disability and quality of life in multiple sclerosis: a 12-year follow-up

    by Gabriel Vieira, Mariana de Sá, Andre Augusto Lemos Vidal de Negreiros, Ana Carolina Andrade, Alfredo Damasceno

    Address for correspondence: Gabriel Vieira (email: gabrieldedeusvieira@gmail.com). Abstract Background: Diffusion-tensor imaging (DTI) is an advanced magnetic resonance imaging (MRI) technique that provides information on microscopic structural damage in white-matter tracts, related to demyelinating and axonal damage. Objective: To evaluate 12-year longitudinal metrics in functional tests and DTI parameters. Methods: We selected 30 patients from a previous cohort, and a new assessment was performed 12 years after (time point 2, tp2) the baseline assessment. The clinical variables evaluated were the EDSS, 9HPT, T25FW, and SDMT. The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) was applied to all patients. We also evaluated the quality-of-life parameters. The DTI images were acquired on a 3-T device and analyzed using MRtrix3 (https://www.mrtrix.org). We selected the following tracts and fascicles: uncinate (UnF), cingulate (CgF), inferior fronto-occipital (IFOF), corpus callosum (CC), corticospinal tract (CST), and the fornix (FxF). Group comparisons were performed with the paired t-test. A multivariable linear regression was also performed. Results: Regarding the functional and cognitive tests, those that showed a significant variation between baseline and tp2 were the EDSS (t (29) = -2.715; p < 0.01), 9HPT (t (40) = -2.202; p < 0.05), and PASAT z-score (t (40) = -2.829; p < 0.01). During baseline, no clinical variables were entered into the equation for DTI analyses. During tp2, the IFOF-FA delta was related to the T25FW (R2 = 0.701; β = -0.992; p < 0.001), the MCC-FA delta was related to fatigue (R2 = 0.289; β = -0.699; p = 0.02), and the UnF-FA delta (R2 = 0.171; β = -0,423; p = 0.009) and the UnF-RD delta (R2 = 0.218; β = -0.466; p = 0.006) were related to depression. Conclusion: In the 12 years of follow-up, damage to the IFOF-FA was a predictor of changes in the T25FWT, in addition to UnF-FA being related to depression. Article published online: 02 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

  • Enlargement of the choroid plexus in pediatric multiple sclerosis

    by Gabriel de Deus Vieira, Fernanda Ferrão Antônio, Alfredo Damasceno

    Some studies have suggested an inflammatory role of the choroid plexus (CP) in the pathophysiology of multiple sclerosis (MS), but mainly in adult patients. We aimed to evaluate clinical and MRI parameters in patients with pediatric-onset multiple sclerosis (POMS). We included 10 patients with POMS and 16 healthy controls (HC), evaluating clinical and neuroimaging variables (cerebral cortex, CP, deep gray matter structures, and demyelinating lesions). Most patients were girls (80%), with a mean age of 15.3 years. POMS individuals had a higher CP volume (p = 0.012) and lower thalamic volume (p = 0.038) compared to HC. This study shows an enlargement of the CP and lower thalamic volume in POMS patients compared to HC.


  • Open Access

    Definition and Characteristics of Multiple Sclerosis with Predominant Cognitive Presentation

    by Amanda Fiori Cavassani, Álix Djone Berté, Andressa Ribeiro Pinto, Marcus Vinicius Magno Gonçalves, Gabriel de Deus Vieira

    We recently reported a longitudinal MRI and cognitive follow-up of a patient with multiple sclerosis with predominant cognitive presentation (MSCP), showing the evolution of the disease and the difficulty in its early diagnosis.